Compound details
Moracin E
| Compound ID | CDAMM00853 |
|---|---|
| Common name | Moracin E | IUPAC name | 5-(6-hydroxy-1-benzofuran-2-yl)-2,2-dimethylchromen-7-ol |
| Molecular formula | C19H16O4 |
| Retention time | 0.45 |
|---|---|
| Adduct | [M+K]+ |
| Actual mz | 347.071 | Theoretical mz | 347.068 |
| Error | 8.19 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.7397 |
| Inchi key | GDSYWTBPYYYLLE-UHFFFAOYSA-N |
|---|---|
| Smiles | OC=1C=CC=2C=C(OC2C1)C=3C=C(O)C=C4OC(C=CC43)(C)C |
| Superclass | Phenylpropanoids and polyketides |
| Class | 2-arylbenzofuran flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P42336 | PIK3CA | PI3-kinase p110-alpha subunit | T80276 | SwissTargetPrediction |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| P21964 | COMT | Catechol O-methyltransferase (by homology) | T76904 | SwissTargetPrediction |
| P14061 | HSD17B1 | Estradiol 17-beta-dehydrogenase 1 | T44011 | SwissTargetPrediction |
| Q08499 | PDE4D | Phosphodiesterase 4D | T02001 | SEA |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SwissTargetPrediction |
| Q07912 | TNK2 | Tyrosine kinase non-receptor protein 2 | T63220 | SwissTargetPrediction |
| P48736 | PIK3CG | PI3-kinase p110-gamma subunit | T95913 | SwissTargetPrediction |
| P15056 | BRAF | Serine/threonine-protein kinase B-raf | T99089 | SwissTargetPrediction |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| P00374 | DHFR | Dihydrofolate reductase | T17345 | SwissTargetPrediction |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T80276 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P42336 | PIK3CA |
| T80276 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P42336 | PIK3CA |
| T80276 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P42336 | PIK3CA |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T76904 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21964 | COMT |
| T02001 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | Q08499 | PDE4D |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T95913 | DI0151 | Follicular lymphoma | [ICD-11: 2A80] | P48736 | PIK3CG |
| T95913 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48736 | PIK3CG |
| T95913 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P48736 | PIK3CG |
| T99089 | DI0252 | Melanoma | [ICD-11: 2C30] | P15056 | BRAF |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T17345 | DI0207 | Indeterminate colitis | [ICD-11: DD72] | P00374 | DHFR |
| T17345 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P00374 | DHFR |
| T17345 | DI0416 | Tuberculosis | [ICD-11: 1B10-1B12] | P00374 | DHFR |
| T17345 | DI0427 | Urinary tract infection | [ICD-11: GC08] | P00374 | DHFR |